Half a million asthma sufferers in the UK could benefit from a "breakthrough" drug that reduces complications caused by the common cold, it was claimed today.
Severe symptoms due to cold infections are one of the chief reasons why asthma patients end up in hospital.
A trial of the new drug, SNG001, at Southampton University, found it significantly reduced asthma symptoms during the critical first week of infection.
Treatment led to a 65% reduction in the number of patients experiencing moderate worsening of symptoms.
More top news
Police have released CCTV footage of a man suspected of breaking in to a home while a woman in her 70s slept in the next room.
Friday afternoon's forecast for the east of the region
Friday afternoon's forecast for the west of the region